Financial Year |
March 31 2023 |
Monetary Funds |
467,287,997.37 |
Held-for-trading Financial Assets |
17,760,743.42 |
Notes Receivable |
19,920,023.94 |
Accounts Receivable |
508,286,333.19 |
Advances to Suppliers |
242,390,490.56 |
Other Receivables |
34,138,572.31 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
2,407,141,942.84 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
15,268,199.06 |
Total Current Assets |
3,712,194,302.69 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
26,949,570.67 |
Investment Properties |
40,663,554.90 |
Fixed Assetes |
2,306,907,764.55 |
Under-construction Projects |
789,800,772.72 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
236,586,660.32 |
R&D expenses |
-- |
Goodwill |
116,973,889.57 |
Long-Term Deferred and Prepaid Expenses |
18,204,612.44 |
Deferred Income Tax Assets |
53,595,125.67 |
Other Non-Current Assets |
75,067,585.93 |
Sub-Total of Non-Current Assets |
4,088,940,462.16 |
Total Assets |
7,801,134,764.85 |
Short-Term Loans |
1,801,994,831.75 |
Trading Financial liabilities |
-- |
Notes Payable |
954,410,586.62 |
Accounts Payable |
726,926,531.13 |
Accounts Received In Advance |
298,238.19 |
Employee Compensation Payable |
42,216,484.59 |
Taxes Payable |
24,345,937.82 |
Interest Payable |
-- |
Dividend Payable |
358,527.35 |
Other payables |
146,837,989.41 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
374,298,762.26 |
Other Current Liabilities |
12,737,163.12 |
Sub-Total of Current Liabilities |
4,223,840,545.77 |
Long-term Loans |
721,201,566.18 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
85,757,365.54 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
39,890,899.16 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,125,781,572.32 |
Total Liabilities |
5,349,622,118.09 |
Paid-In Capital(Or Share Stock) |
436,134,976.00 |
Capital Surplus |
892,875,614.93 |
Surplus Reserve |
102,548,354.86 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
602,836,402.18 |
Minority Stockholder's Interest |
410,471,687.56 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,041,040,959.20 |
Owner's Equity(Stockholder's Equity) |
2,451,512,646.76 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
7,801,134,764.85 |